Polymorphism of the cytochrome P450 (CYP) 2C9 gene in Japanese epileptic patients:: genetic analysis of the CYP2C9 locus

被引：119
|
作者：
Imai, J
Ieiri, I
Mamiya, K
Miyahara, S
Furuumi, H
Nanba, E
Yamane, M
Fukumaki, Y
Ninomiya, H
Tashiro, N
Otsubo, K
Higuchi, S
机构：
[1] Tottori Univ, Fac Med, Dept Hosp Pharm, Yonago, Tottori 6838504, Japan
[2] Tottori Univ, Ctr Gene Res, Yonago, Tottori 6838504, Japan
[3] Kyushu Univ, Inst Genet Informat, Higashi Ku, Fukuoka, Japan
[4] Kyushu Univ, Fac Med, Div Pharmaceut Sci, Higashi Ku, Fukuoka, Japan
[5] Kyushu Univ, Fac Med, Dept Neuropsychiat, Higashi Ku, Fukuoka, Japan
来源：
PHARMACOGENETICS | 2000年 / 10卷 / 01期
关键词：
CYP2C9; genetic analysis; polymorphism; new mutations; Japanese;
D O I：
10.1097/00008571-200002000-00011
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
[No abstract available]
引用
收藏
页码：85 / 89
页数：5
相关论文
共 50 条
  • [1] Genetic analysis of the human cytochrome P450 CYP2C9 locus
    Stubbins, MJ
    Harries, LW
    Smith, G
    Tarbit, MH
    Wolf, CR
    PHARMACOGENETICS, 1996, 6 (05): : 429 - 439
  • [2] Cytochrome P450 2C9 (CYP2C9) polymorphisms in Chinese Li population
    Ding, Yipeng
    Yang, Danlei
    Zhou, Long
    He, Ping
    Yao, Jinjian
    Xie, Pingdong
    Lin, Daobo
    Sun, Dingwei
    Sun, Pei
    Li, Quanni
    Geng, Tingting
    Jin, Tianbo
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (11): : 21024 - 21033
  • [3] Oesophageal cancer proliferation is mediated by cytochrome P450 2C9 (CYP2C9)
    Dizdar, L.
    Schmelzle, M.
    Wolters, J.
    Lindenlauf, N.
    Baldus, S. E.
    Topp, S. A.
    Esch, J. Schulte Am, II
    Eisenberger, C. F.
    Stoecklein, N. H.
    Knoefel, W. T.
    EJC SUPPLEMENTS, 2010, 8 (05): : 134 - 134
  • [4] Esophageal cancer proliferation is mediated by cytochrome P450 2C9 (CYP2C9)
    Schmelzle, Moritz
    Dizdar, Levent
    Matthaei, Hanno
    Baldus, Stephan E.
    Wolters, Judith
    Lindenlauf, Nina
    Bruns, Ingmar
    Cadeddu, Ron-Patrick
    Kroepil, Feride
    Topp, Stefan A.
    Esch, Jan Schulte Am, II
    Eisenberger, Claus F.
    Knoefel, Wolfram T.
    Stoecklein, Nikolas H.
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2011, 94 (1-2) : 25 - 33
  • [5] Genetic polymorphism of cytochrome P450s, CYP2C19, and CYP2C9 in a Japanese population
    Kimura, M
    Ieiri, I
    Mamiya, K
    Urae, F
    Higuchi, S
    THERAPEUTIC DRUG MONITORING, 1998, 20 (03) : 243 - 247
  • [6] Cytochrome P450 2c9 (CYP2C9) metabolic capacity in people with and without cancer.
    Shord, S. S.
    Cavallari, L. H.
    Viana, M. A.
    Momary, K.
    Molokie, R. E.
    Neceskas, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S50 - S51
  • [7] Genetic analysis of CYP2C9 polymorphism in a Japanese population
    Nasu, K
    Kubota, T
    Ishizaki, T
    PHARMACOGENETICS, 1997, 7 (05): : 405 - 409
  • [8] Cytochrome p450 CYP2C9 and CYP2C19 genetic polymorphisms in croatian children with epilepsy
    Gjergja, R.
    Cvitanovic-Sojat, L.
    Bielen, L.
    Sojat, T.
    Stefanovic, M.
    EPILEPSIA, 2006, 47 : 182 - 183
  • [9] Cytochrome P450 2C9-CYP2C9
    Van Booven, Derek
    Marsh, Sharon
    McLeod, Howard
    Carrillo, Michelle Whirl
    Sangkuhl, Katrin
    Klein, Teri E.
    Altman, Russ B.
    PHARMACOGENETICS AND GENOMICS, 2010, 20 (04): : 277 - 281
  • [10] Distribution of the Major Cytochrome P450 (CYP) 2C9 Genetic Variants in a Saudi Population
    Mirghani, Rajaa A.
    Chowdhary, Gulnaz
    Elghazali, Gehad
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 (02) : 111 - 114
12345